Healthy volunteers help measure blood sugar effects of nutritional drinks
NCT ID NCT07243743
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how certain nutritional products affect blood sugar levels in healthy adults. Fourteen volunteers, aged 18 to 65 with a normal body weight, each consumed a test product or a reference product after fasting. Their blood sugar was measured before and several times over two hours. The goal was to calculate the glycemic index of the test products.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
14 people
The number who actually took part.
- Started
-
Oct 2025
- Finished
-
Dec 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥ 18 and ≤ 65 years 2. Body mass index (BMI) between 18.5 and 27 kg/m² Exclusion Criteria: 1. Fasting Glucose ≥6.1 at screening visit 2. Known history of gastrointestinal disease, bariatric surgery, AIDS, hepatitis, a history or presence of clinically important endocrine (including Type 1 or Type 2 diabetes mellitus), or any condition which might, in the opinion of the medical director either: 1) make participation dangerous to the subject or to others, or 2)affect the results. 3. Use of medications known to influence carbohydrate metabolism, gastrointestinal function or appetite, including, but not limited to adrenergic blockers, diuretics, thiazolidinediones, metformin and systemic corticosteroids within 4 weeks of the screening visit, or any medication which might, in the opinion of the medical director either: 1) make participation dangerous to the subject or to others, or 2) affect the results. 4. Major trauma or surgical event within 3 months of screening. 5. Known intolerance, sensitivity or allergy to test products. 6. Extreme dietary habits, as judged by the Investigator (i.e. Atkins diet, very high protein diets, etc.). 7. History of cancer in the prior two years, except for non-melanoma skin cancer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Glycemic response are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
INQUIS Clinical Research, Ltd , 20 Victoria Street, 3rd Floor
Toronto, Ontario, M5C 2N8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.